Low serum high‐density lipoprotein cholesterol in childhood is associated with adolescent asthma

Abstract

Whilst emerging evidence from animal and cell experiments has shown high-density lipoprotein cholesterol to have anti-inflammatory effects consistent with a protective role in asthma, human studies investigating the relationship of high-density lipoprotein cholesterol with asthma have produced conflicting results. To examine the association between serum lipids among Cypriot children aged 11-12years and prevalence of asthma at age 15-17years. In 3982 children, we assessed serum lipids, body mass index and maximal oxygen consumption at baseline (2001-2003) and explored associations with respiratory health at follow-up (2007) using multiple logistic regression models. Lower levels of high-density lipoprotein cholesterol at age 11-12years were found in subjects who reported ever asthma (58.2 vs. 60.0mg/dL, P=0.005) and active asthma (57.5 vs. 59.9mg/dL, P=0.010) in adolescence, in comparison with their respective reference groups. Total cholesterol, low-density lipoprotein and triglycerides had no association with any of the asthma outcomes. In contrast, with estimated odds ratios of 1.89 (95% CI 1.19-3.00) and 1.89 (95% CI 1.02-3.53), ever asthma and active asthma respectively appeared particularly pronounced among those who at baseline had high-density lipoprotein cholesterol <40mg/dL, even after adjusting for potential confounders including body mass index and maximal oxygen consumption. Low-serum high-density lipoprotein cholesterol in childhood is associated with an increased risk for asthma in adolescence, suggesting a potential role of this lipoprotein in the pathogenesis of paediatric asthma.